Neocis secures US$40m in new funding

Neocis, manufacturer of the Yomi robot-assisted dental implant surgery system, has secured US$40m in additional funding.

Neocis’ latest round of funding is led by a prominent dental investor, with participation from Intuitive Ventures and existing partners DFJ Growth, Vivo Capital, Mithril Capital Management, Norwest Venture Partners, and Fred Moll.

The rise of robot-assisted dental implant surgery

This additional funding reflects the growing interest in robot-assisted dental implant surgery.

 According to a press release from Neocis, the Yomi robotic dental implant system has been used to place more than 20,000 implants.

Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental implant surgery, announced today that the company has completed its latest round of financing.

Total funds reach US$160m

The funding round was led by one of the dental industry’s largest specialist investors, joined by Intuitive Ventures, the independent VC arm of Intuitive Surgical.

In addition to Neocis’ existing portfolio of funds, the new investors bring the total funds of the Miami-based business to more than US$160 million since its inception in 2009.

Founded by Alon Mozes and Juan Salcedo, Neocis is the manufacturer of Yomi, known as dentistry’s first and only FDA-cleared robotic surgical system.

Operating within the YomiPlan software suite and robotic guidance of surgical instrumentation, Yomi is designed to assist clinicians during all phases of implant placement via interactive digital planning.

Click here to read DRA Technology Update: Dental Products 2022

Neocis a “transformative force”

According to Neocis, the technology features streamlined digital planning and haptic guidance of surgical instrumentation for placing implants with accuracy, efficiency, and confidence.

The Yomi system is often used to perform flapless procedures, a less invasive surgical approach with proven patient benefits.

“Neocis shares Intuitive Ventures’ commitment to advancing positive patient outcomes in minimally invasive care through innovative technology and solutions,” said Oliver Keown, MD, Managing Director at Intuitive Ventures.

“We believe Neocis’ deep commitment to addressing customer and patient need through a broadening robotic ecosystem and their impressive technology platform that expands access to high-quality dental care, makes them a transformative force in this rapidly evolving market.”

Yomi and other innovations are profiled in DRA Technology Update: Dental Products 2022

Limitless future of dental robotics

According to the press release, Neocis will use the latest infusion of capital to continue accelerating research and development efforts, bolstering marketing and educational initiatives, and expanding the footprint of its sales, clinical support, and business optimization teams.

“We are thrilled to be joined by discerning investors aligned with Neocis’ mission to advance precision dentistry,” said Ajay Royan, Managing General Partner and Founder of Mithril Capital Management, an early investor in Neocis.

“The future of dental robotics is limitless, and this latest round of capital will help the Neocis team continue innovating at the highest level.”

“For a company in the dental robotics space, I couldn’t dream up a better syndicate of investors than this,” said Alon Mozes, Neocis Co-Founder and CEO.

“This new backing underscores Neocis’ strong position in a growing market and will help us further our product development and commercial efforts.”

The finalization of this new round of funding comes just a few months after Yomi was named one of the winners of the Cellerant Best of Class Technology Award.

Click here for more information on Neocis and the Yomi system.